How a Lab Accident Led to the Discovery of Lifesaving Cancer Drug Cisplatin
Lab Accident Led to Discovery of Cancer Drug Cisplatin

The Accidental Discovery of Cisplatin

In 1965, Barnett Rosenberg, a biophysicist at Michigan State University, was conducting a basic experiment to study how electric fields affected cell division in E. coli bacteria. He was not searching for a cancer treatment, but a strange occurrence in his laboratory would lead to the discovery of cisplatin's anti-cancer potential.

During the experiment, Rosenberg observed that the bacteria failed to divide normally and instead grew into long, narrow filaments. This unexpected event was the starting point for developing cisplatin, a highly successful drug used against testicular, ovarian, and bladder cancers.

Accidental Discovery in the Laboratory Dish

The accidental discovery happened because of the specific electrodes Rosenberg used. He thought using supposedly inert platinum electrodes was appropriate, but a small amount of platinum dissolved and reacted with the solution. This led to a new chemical substance that prevented bacterial division while allowing growth.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

According to the National Cancer Institute, Rosenberg had a hunch that if this platinum compound could prevent bacterial division, it might also stop cancer tumors, which grow through rapid cell division. Filamentation is the anomalous growth observed in certain bacteria.

From Experiment to Medical Use

Turning this idea into reality was a long and difficult process. According to a PubMed medical review, scientists tested the compound on lab rats with lethal tumors, showing excellent results: it inhibited cancerous cell growth and reduced tumor size. This proved the discovery was not just a lab accident but a medically feasible treatment.

A Long Journey to Patient Treatment

Although discovered in 1965, it took another ten years for cisplatin to reach patients. Converting a laboratory compound into a clinical medication requires strict safety precautions. Cisplatin entered clinical trials and received FDA approval in 1978.

Today, cisplatin remains a potent weapon against testicular, ovarian, and bladder cancers. It also enabled the development of other platinum-based drugs, saving lives worldwide. The story of cisplatin highlights the importance of careful observation in scientific discovery.

Pickt after-article banner — collaborative shopping lists app with family illustration